V-Card | Print | PDF | Email Page

Joshua Berick (Josh)


(T) +1.212.326.3486
(F) +1.212.755.7306


  • Columbia University (J.D. 1997; Harlan Fiske Stone Scholar; B.A. magna cum laude 1992)

Bar Admissions

  • New York

Josh Berick advises private equity funds and strategic investors on M&A transactions, control and minority investments, and joint ventures, including in the life sciences, technology, and energy industries. He has extensive international experience, having led complex cross-border transactions in the United Kingdom, Europe, Asia, and Latin America.

Since joining Jones Day in 2017, Josh has represented EagleTree Capital in its acquisition of CORSAIR, Verizon in the sale of cloud and managed hosting assets to IBM, Royalty Pharma in its acquisition of Arteaus Therapeutics' royalty on Eli Lilly's EMGALITY, GE Healthcare in its strategic partnerships with Roche (to develop an integrated digital diagnostics platform for oncology and critical care treatment) and Preventice Solutions (to develop an ambulatory cardiac arrhythmia monitoring suite), and Eni Next in its strategic investment in Commonwealth Fusion Systems.

Prior to joining the Firm, Josh represented BP in numerous matters, including its US$7 billion acquisition of oil and gas assets in the Gulf of Mexico, Brazil, and Azerbaijan from Devon Energy Corporation; the Special Committee of the Board of Directors of American Realty Capital — Retail Centers of America, Inc. in its US$1.4 billion merger with American Finance Trust; CPA Global Limited, a Cinven portfolio company, in its acquisitions of Landon IP Inc. and Innography, Inc.; and American International Group on the sale of its consumer finance businesses in Hong Kong, Taiwan, Thailand, and the Philippines.

Josh is a frequent contributor to articles on Delaware and New York law issues arising in private equity and M&A transactions.

Joshua Berick Josh